CONTRACT s! te $4 Save ga le 00 09 by de 20 y e st Pa or m MANUFACTURING & gu nd or Au r a 3 28 iste r fo g nt Re ou sc OUTSOURCING Di up ro G % 10 y jo for Pharmaceutical En 28-29 OCTObeR 2009 l ROyAl PlAzA ON SCOTTS HOTel, SINGAPORe exPlORING FUTURe OF CMO MARkeT: eMeRGING dRIveRS, bUSINeSS MOdelS ANd PROdUCTION STRATeGIeS INCReASe GlObAl COMPeTITIveNeSS! exPANd yOUR CAPACITy! Identify latest key issues and developments in the contract Adopt new approaches from the best contract manufacturers in Asia. manufacturing market: PIRAMAl HeAlTHCARe lIMITed INC (USA) AlkeM lAbORATORIeS lTd (INdIA) GlObAl CMO MANAGeMeNT N. Santhanam, Executive Director and vinod Dua, President-Marketing & Sales Chief Operating Officer l CMO perspective l Pharma perspective A-bIO PHARMA (SINGAPORe) leveRAGING lOw COST MANUFACTURING lOCATIONS Dr. Steven Lee, Chief Executive Officer lONzA INveSTMeNT COMPANy lTd. l China updates l India updates (CHINA) beACONS PHARMACeUTICAlS ANd Huang Jinquan Wilvan, Operational HeAlTH PROdUCTS (SINGAPORe) New PARAdIGM IN CMO CONTRACTING Excellence Manager & Lean Six Sigma Blackbelt Joseph Lam, Managing Director l New key criteria for CMOs l empowering collaborations l Improving pharma productivity l Advantages and disadvantages of outsourcing OUTSOURCING MANUFACTURe dURING eCONOMIC dOwNTURN l Minimising costs deSIGN A SUITAble MANUFACTURING STRATeGy! l Hidden costs, revenue, profits considerations Apply best practices of small/large pharma and biotech companies. SeleCTING CMO PARTNeRS eISAI PHARMATeCHNOlOGy ANd GlObAl PHARMACeUTICAl SUPPly l Methods in evaluating a contractor MANUFACTURING (INdIA) CHAIN (GPSG) (SINGAPORe) l benchmarking and measuring effectiveness of CMO Sanjit Singh Lamba, President Tony Uhe, Senior Director External Manufacturing Quality Operations Asia Pacific UNdeRSTANdING THe CONTRACT wellFORM lIFe SCIeNCeS (MAlAySIA) SHANGHAI FOSUN OMNI vaidyanathan Nateshan, CEO l Technique and strategy in negotiating, drafting, managing contract PHARMACeUTICAl (CHINA) l effective negotiation for outsourcing contracts PFIzeR ASIA MANUFACTURING PTe. lTd. Larry Schuster, International Business l breach of contract and resolution Development Manager (SINGAPORe) COUNTeRING CHAlleNGeS IN OUTSOURCING Sunil Ghogre, Senior Director/Team Leader SHANGHAI FOSUN PHARMACeUTICAl – Global Contract Manufacturing Asia Region CO. lTd. (CHINA) l Managing legal risks l Protecting business interest Cui Zhiping, VP, International Department l IPR issues and IP ownership TeCHNOlOGy evAlUATION ANd TRANSFeR l latest trends and developments l Product development l Multiple and diverse technology platform l biotechnology evolution PROTeCT yOUR bUSINeSS! Take legal advice in pharma. IMPROvING PARTNeRSHIPS l Stronger links between organisations dRew & NAPIeR llC (SINGAPORe) SeeRPHARMA (SINGAPORe) l effect of acquisitions, mergers, in-licensing in the supply chain Benjamin Gaw, Associate Director Speaker to be announced management PHARMOUT PTy. lTd. (AUSTRAlIA) l Management of a relationship with a CMO John Montalto Senior Consultant, Training Services ATTeNd THIS CONFeReNCe! ORGANISed by: OFFICIAl MedIA PARTNeRS: Exchange ideas. 3 16 Speakers from Global Pharma and CMO 3 2 Panel discussions: l Effective CMO Management Structures l The Future of Drug Manufacturing in Asia 3 ½-dAy POST-CONFeReNCe wORkSHOP led by INdIA’S bIGGeST CMO, PIRAMAl (30 OCTObeR 2009, FRIdAy) 3 India and China Updates 3 Networking Opportunities For enquiries and registration: Call (65) 6536 8676 or (65) 6536 8437 or visit us at www.abf-asia.com boosting productivity and efficiencies through effective CMO collaborations • Managing the risk 28 OCTObeR 2009 wednesday day 1 • • Risk profile for a contract manufacturing company Type and nature of risks for the company that contract manufactures 8:00 REGIsTRATIon AnD MoRnInG CoffEE vaidyanathan Nateshan Chief Executive Officer 9:00 CHAIRPeRSON’s OPeNING ReMARkS WeLLForM LiFe SCieNCeS, MaLaySia Larry Schuster .................................................................................................. International Business Development Manager Nateshan is the co-founder and CEO of Wellform Kinetics SDN BHD, the Malaysian subsidiary SHaNGHai FoSUN oMNi PHarMaCeUTiCaL, CHiNa of Wellform Life Sciences Inc. He brings with him an invaluable combination of downstream .................................................................................................. expertise and a very considerable reputation for managing a large-scale global business. He holds a Bachelor’s degree in Economics with 9 years of experience in the field of sales and Larry represents Omni Pharma’s business development interests globally as it builds an business development in established large companies and specialises in Contract negotiations, international portfolio of strategic partnerships and investors. For the previous 20 years, he was Deal Creation, Mergers & Acquisitions, Managing relationships & Joint Ventures. in international medical and science communications, mostly based in the United States, as a writer/ editor for medical magazines for doctors, and for medical news agencies, including Reuters Health. In the 1990s, for six years, he was Science and Technology Editor for the global news 12:00 UNdeRSTANdING CONTRACTS ANd THe CONTRACT PROCeSS agency, United Press International (UPI), in Washington, DC. • Effective technique and strategy in drafting, managing contracts key dRIveRS OF CMO: PHARMA PeRSPeCTIve • Understanding the contract • Breach of contract and resolution 9:15 OUTSOURCING – STRATeGy FORMATION TO SUCCeSSFUl • Renegotiating and terminating contract IMPleMeNTATION manufacturing • Long term strategy • Quality agreement • Vendor screening, due diligence and selection Benjamin Gaw process Associate Director • Defining scope and expectations DreW & NaPier LLC, SiNGaPore • Managing and building business relationship .................................................................................................. • Business continuity plans and business review Benjamin’s areas of practice range from corporate and finance to insolvency and restructuring meetings work. He has also regularly advised numerous biotechnology, health and pharmaceutical companies on regulatory and contractual issues in Singapore, including advising on clinical Sunil Ghogre trial agreements, R&D agreements, manufacturing and supply agreements and distribution Senior Director/Team Leader – Global Contract agreements. He is the author of “Legislating the Fruits of Biotechnology: Suggestions for Manufacturing Asia Region Regulating Bio-engineered Food”, a co-contributor to the Atkin’s Court Forms, to an article in the PFiZer aSia MaNUFaCTUriNG PTe. LTD., SiNGaPore Singapore Biotech Guide 2007/2008 and to the “Global Pharmacovigilance Laws & Regulations: .................................................................................................. The Essential Reference”. Sunil holds a B.S. in Pharmacy and a Master’s degree in Management from the University of Bombay. He began his professional career with Procter and Gamble in 1979 and had various 12:45 LUnCh operational responsibilities in plant and contract manufacturing operations for over 18 years. He joined Pfizer in 1997 as a site leader of Hyderabad, India plant, and managed Pfizer India contract manufacturing operations before moving to Pfizer headquarter in New York to lead Pfizer Global 2:00 IMPACT/INFlUeNCe OF ReGUlATORy CHANGeS TO THe Manufacturing (PGM) Operational Excellence (Right First Time) initiative for the Asia, and Africa, CONTRACT MANUFACTURING MARkeT Middle East manufacturing sites. • Pressure to meet increasingly demanding quality control criteria from international regulatory 10:00 beST PRACTICeS IN SeleCTING CMO PARTNeRS • Regulations related to manufacturing • Methods in evaluating a contractor • Regulatory scenario in CMo • selecting the correct partner John Montalto • Assessing risks and benefits Senior Consultant, Training Services • Review of contractor’s requirements PHarMoUT PTy. LTD., aUSTraLia • factors in successful collaboration .................................................................................................. • Which manufacturing functions need to be kept John has worked with clients in the areas of pharmaceutical validation project management, quality management systems implementation and risk management. These include overall responsibility internal for several ‘turn-key’ manufacturing projects at GSK and Kodak. John began his career working • Utilising internal core expertise in plant operations in the pharmaceutical industry with CSL Limited, followed by Operations Sanjit Singh Lamba manufacturing management positions and lean manufacturing positions in the chemical industry. President He currently sits on the board of directors of the Australian affiliate of the ISPE. He holds a B. Sc. from La Trobe University and a Graduate Diploma in Management from RMIT University. eiSai PHarMaTeCHNoLoGy aND MaNUFaCTUriNG, iNDia .................................................................................................. Sanjit has over 20 years of experience in the field of Pharmaceutical Manufacturing. He has key dRIveRS OF CMO : CMO PeRSPeCTIve held various positions in different organisations and has been responsible for Technical & Business Operations at various levels for Global Pharmaceutical companies like Merck Sharp 2:45 COST-eFFeCTIve PROCeSS ANd TeCHNOlOGy develOPMeNT & Dohme, Pfizer, Dabur and lupin. Before Joining Eisai, he held a position of Director – Global Pharma Manufacturing at Ranbaxy. He is associated with the Indian Pharmaceutical Association, FOR IMPROvING bIOlOGICS MANUFACTURING – A CMO Parenteral Drug Association, International Society for Pharmaceutical Engineers (ISPE),and PeRSPeCTIve Organisation of Pharmaceutical producers of India (OPPI). • Process is the product - Process development plays a critical role for manufacturing biologics 10:45 MoRnInG REfREshMEnT • Recent trends in drug development model for biological products – Integrated process kNOwING THe leGAl ISSUeS IN CMO development and outsourcing • Broad ranges of biological products demand 11:15 MANAGING RISkS IN OUTSOURCING MANUFACTURING multiple and diverse technology platforms • Risk profile for a company that outsources • Enhanced CMo process and technology • Type and nature of risks for the company that development capabilities required for successful outsources partnership in global markets For enquiries and registration: Call (65) 6536 8676 or (65) 6536 8437 or visit us at www.abf-asia.com • new paradigm for value-added CMo services ACHIevING bUSINeSS exCelleNCe beyond cost-effectiveness • Case study of successful projects from tech 9:15 OPeRATIONAl exCelleNCe (leAN SIx SIGMA) IN CUSTOM transfer to quality and timely delivery MANUFACTURING • Lessons learned from less-than successful projects • Introduction to operational excellence, lean six Dr. Steven Lee sigma Chief Executive Officer • operational excellence in pharmaceutical a-Bio PHarMa PTe LTD, SiNGaPore .................................................................................................. industry/business Dr. Steven heads one of Asia’s leading biologics contract manufacturers, A-Bio. A-Bio provides a • Why operational excellence in custom full range of capabilities and services for biologics manufacturing, including cell culture process manufacturing development, optimisation and scale-up, cGMP manufacturing of pre/clinical material, novel • operational excellence in Lonza manufacturing technology development, quality services and regulatory strategy and compliance. Prior to joining A-Bio, he was the Vice-President and General Manager, Process Development and • operational excellence future in CMo Biologics Manufacturing of Bristol-Myers Squibb Company. He received his doctorate in Biochemical Huang Jinquan Wilvan Engineering from the Massachusetts Institute of Technology (MIT), Cambridge, MA, USA. Operational Excellence Manager & Lean Six Sigma Blackbelt 3:30 AfTERnoon REfREshMEnT LoNZa iNveSTMeNT CoMPaNy LTD., CHiNa .................................................................................................. 4:00 eFFeCTIve MANAGeMeNT OF A RelATIONSHIP wITH A CMO Wilvan is an accomplished statistician with an established track record in providing pragmatic • CMos as strategic partner vs transactional supplier Statistical & Operational Excellence (OE) consultancy in product development & manufacturing. He has a track record of business improvement through the application of OE principles (Lean • CMos evaluated as an agent for reducing supply & 6-Sigma). With 7 years of pharmaceutical industry experience, he has a broad business chain complexity while balancing capacity and understanding and management expertise. Currently, he is part of a newly formed OE team in cost considerations building & promoting OE culture and ways of working with one of the world’s leading suppliers to • supporting the CMo in achieving compliance with the pharmaceutical, healthcare and life science industries. internal standards • operational review mechanisms for expanding 10:00 CHINeSe PHARMACeUTICAl COMPANIeS: TRANSITION FROM existing relationships CMO TO beCOMING GlObAl GeNeRICS PlAyeR N. Santhanam • Chinese pharma as the largest API manufacturing Executive Director and Chief Operating Officer and exportation country PiraMaL HeaLTHCare LiMiTeD, USa • Catching up with the Indian pharma .................................................................................................. • Possibilities and opportunities to be largest N. Santhanam is a Chartered Accountant with a brilliant academic career and is a Rank Holder. generics formulation player He has 35 years of rich and varied experience in Corporate Accounts, Finance, Secretarial and Legal apart from gaining deep insight into general business management. The first 7 years of his • Developing generics product career were spent with the Tata Group, Mumbai and thereafter a long haul of 22 years with the • The pros and the cons Wadia Group. Since August 2008, he has been the COO of Piramal and has total responsibility Cui Zhiping of its Healthcare Solutions, Pharma Solutions, Global Critical Care, Diagnostic Equipments and Vitamins and Fine Chemicals businesses. Vice President, International Department SHaNGHai FoSUN PHarMaCeUTiCaL Co. LTD., CHiNa .................................................................................................. 4:45 eSTAblISHING eFFeCTIve CMO MANAGeMeNT STRUCTUReS Cui is responsible for group global development strategy and implementation. He started as a • outsourcing in Asia vs lean manufacturing in Europe quality control staff in Shanghai Medicinal Corp. in 1986, and has successfully published more dISCUSSION • Identifying cost-savings associated with than 10 R & D research papers. As the Vice General Manager of Shanghai Pharmaceutical Co., outsourcing to low cost countries Ltd from 2000 to 2004, he has successfully managed his business unit and made international PANel • overcoming challenges associated with outsourcing trading revenue growth of more than 10 times within 5 years. He has also been appointed as a consultant of ‘Shanghai Economic Relation & Trade Commission’. He has received MBA to Asia degree from Le Trobe University in Australia in 2000, and pharma D from Shanghai Medical • outsourcing in the current economic environment University in 1986. • Identifying suppliers and managing relationships MoDERAToR: 10:45 MoRnInG REfREshMEnT John Montalto, Senior Consultant, Training Services PHarMoUT PTy. LTD. aUSTraLia INCReASING CMO CAPACITy PAnELIsTs: 11:15 beNCHMARkING ANd MeASURING eFFeCTIveNeSS OF CMO Sanjit Singh Lamba, President • Defining most efficient means of quality control eiSai PHarMaTeCHNoLoGy aND MaNUFaCTUriNG, iNDia • Auditing as a mean to evaluate a CMo’s conformance vaidyanathan Nateshan, Chief Executive Officer WeLLForM LiFe SCieNCeS, MaLaySia • Managing relationships to maximise performance • financial management of manufacturing sites Dr. Steven Lee, Chief Executive Officer • Review of site’s KPI and review consistency with a-Bio PHarMa PTe LTD, SiNGaPore financial results speaker to be announced vineet Luhariwala, Vice President, Formulations SeerPHarMa Business Development, PiraMaL HeaLTHCare, USa 12:00 PIONeeRING vAlUe INNOvATIve CONTRACT MANUFACTURING 5:30 eNd OF dAy ONe • More than just pipeline performance, corporate performance is also depended on drug launching and manufacturing performance 29 OCTObeR 2009 Thursday day 2 • strategy to mitigate drug launch risk, improve cash flow and outperform the competition using value innovative contract manufacturing 8:30 MoRnInG CoffEE • new proposed contract manufacturing solutions and innovation 9:00 CHAIRPeRSON’s OPeNING ReMARkS Joseph Lam Huang Jinquan Wilvan Managing Director Operational Excellence Manager BeaCoNS PHarMaCeUTiCaLS aND HeaLTH ProDUCTS, & Lean Six Sigma Blackbelt SiNGaPore LoNZa iNveSTMeNT CoMPaNy LTD., CHiNa .................................................................................................. For enquiries and registration: Call (65) 6536 8676 or (65) 6536 8437 or visit us at www.abf-asia.com Joseph graduated from Ohio State University with BS Pharmacy in 1994 and he has 14 years experience in the pharmaceutical industry. He is the inventor of Satellite Process Assurance Hub Moderator: (SPAH) System Technology, and holds other patents. He is also a member of the International Huang Jinquan Wilvan, Operational Excellence Society for Pharmaceutical Engineering (ISPE). Manager & Lean Six Sigma Blackbelt LoNZa iNveSTMeNT CoMPaNy LTD., CHiNa 12:45 LUnCh 2:00 COUNTeRING CHAlleNGeS IN OUTSOURCING Panelists: • Identifying and managing risks Joseph Lam, Managing Director • Risk of pilferage BeaCoNS PHarMaCeUTiCaLS aND HeaLTH ProDUCTS, • Product safety complaint vigilance SiNGaPore • GMP compliance issues • Counterfeiting Cui Zhiping Tony Uhe Vice President, International Department Senior Director Quality Operations External SHaNGHai FoSUN PHarMaCeUTiCaL Co. LTD., CHiNa Manufacturing Asia Pacific GLoBaL PHarMaCeUTiCaL SUPPLy CHaiN (GPSG), Tony Uhe, Senior Director Quality Operations External SiNGaPore Manufacturing Asia Pacific .................................................................................................. GLoBaL PHarMaCeUTiCaL SUPPLy CHaiN (GPSG), Tony has over 20 years experience in the pharmaceutical industry including: J&J - 3.5 years SiNGaPore External Manufacturing QA, 5 years Head of Quality for API site; GSK - 7 years in R&D QA, Quality Manager; Generic Manufacturer Sterile/Anticancer Products, 5 years R&D and IT, vinod Dua, President-Marketing & Sales Analytical Services Manager, LIMS Manager. His current responsibilities include: 45 External Manufacturers across AP region, global risk based assessment toll for assessment of External aLkeM LaBoraTorieS LTD, iNDia Manufacturers, due diligence of new EMs, support all dosage forms, sterile products, medical devices, and biologics, EMs range from MNCs to small locally owned companies and EM’s 5:45 eNd OF CONFeReNCe supplying all markets in AP, as well as USA, Europe, and Australia. INdIA ANd CHINA CMO UPdATeS ly SePARATele ½-dAy POST-CONFeReNCe 2:45 leveRAGING lOw COST MANUFACTURING lOCATIONS: bOO kAb OUTSOURCING IN INdIA wORkSHOP • Best practices and case studies 30 OCTObeR 2009, FRIdAy • Patent situation and implications • new integrated business model • Challenges • Expansion strategies CMO in 2012: The wishlist vinod Dua (Hear it from the largest Contract Manufacturing President-Marketing & Sales Organisation in India!) aLkeM LaBoraTorieS LTD, iNDia .................................................................................................. Vinod has been associated with the pharmaceutical industry since 1975. Vinod’s role as workshop Objective: President of Alkem is to manage top line and profitability in line with corporate objective split among the domestic divisions. He began his career as a Professional Service Representative To be able to know the areas where asian CMos have with then U.S.Schering. Having worked in some of the best MNCs and Indian companies, he rose most ground to cover vis-a-vis western CMos. through the ladder to become the current President. He is a Post Graduate in Biological Sciences and has studied a Post Graduate Management Programme in Marketing (Master in Marketing Management-MMM) from one of the reputed Management Institutes of MUMBAI India. workshop Outline: 3:30 AfTERnoon REfREshMEnT How is it working with Asian CMOs? 4:15 OUTSOURCING FROM CHINA: PeRSPeCTIve FROM 3-yeAR Old FORMUlATION COMPANy bUIlT ON U.S. exPeRTISe what is the perception of CMO readiness on scalability, quality, • Developing drugs with manufacturing in mind reliability? • Inhalation drug expertise: A pearl of the China what are the benefits of outsourcing in Asia? pharmaceutical industry what are the CMO issues on environment health and safety, IP • Key challenge: how to find a CMo to work with? compliance, regulatory challenges? • Concerns with IP protection, cGMP status and what is the role of customer service, and how do you improve it? compliance • handling technically challenging formulations and what are the metrics to be considered while selecting a partner? processes • Looking back to U.s. for CMo, CRo (Bioequivalency studies) services About your workshop leader: • Partnering with distributors/manufacturing for generics products and with brand pharma vineet luhariwala • Best practices Vice President, Formulations Business Development Larry Schuster PIRAMAl HeAlTHCARe lIMTed INC, USA International Business Development Manager SHaNGHai FoSUN oMNi PHarMaCeUTiCaL, CHiNa Vineet is a Chemical Engineer and has completed a MBA programme in Finance and Operations. He has been with Piramal Healthcare for 7 years and involved with the conceptualisation and growth of the CMO business unit of the 5:00 THe FUTURe OF dRUG MANUFACTURING IN ASIA organisation. He has held several roles of Strategic planning, key accounts • Market developments, technology transfer, key management, High Potency APIs unit head and Business development over dISCUSSION success factors the last 7 years. Prior to Piramal Healthcare, Vineet spent 5 years with top • The role of new technologies and outsourcing in Management Consulting firms Accenture and AT Kearney Ltd in areas of Process PANel streamlining operations redesign and strategic planning. Vineet currently heads business development • Understanding how CMo market will develop for the fast growing formulations development and commercial supply segment beyond 2009 of the CMO business unit and has responsibilities for USA/EU/Asia. • Assessing future outsourcing trends and strategies • Maintaining competitiveness in a rapidly changing Schedule: Registration starts at 8:30am. Workshop session commences at 9:00am with environment half-hour mid-morning break and ends at 12:30pm. For enquiries and registration: Call (65) 6536 8676 or (65) 6536 8437 or visit us at www.abf-asia.com bUIldING GReATeR OPeRATIONAl FlexIbIlITy ANd INCReASING eFFICIeNCy THROUGH CMO STRATeGIeS ASIA CMO IS beCOMING A GlObAl FORCe wHO SHAll ATTeNd? The dynamics of the contract manufacturing landscape in the pharmaceutical n Pharmaceutical industry are changing. The market is becoming increasingly globalised, with the shift Companies of services from the West to the East. CMo companies shall be able to attend to the n Biopharm changing needs of their clients and better their quality and scope of services. n Biotech n Contract STAy COMPeTITIve Manufacturing There are many reasons why a pharma company should outsource manufacturing, organisations but the most compelling is “to stay competitive”, while maintaining a world-class level of quality. outsourcing shall enable the company to reduce excess capacity in directors, Heads, vPs, manufacturing networks and restructure supply chains. A company’s position in the Managers marketplace will not only be strengthened, but will have additional resources to stay ahead of the competition in these uncertain times. v Manufacturing As a CMo and as a Pharma company, you should have these questions. v Production v Business what are the key trends in the global pharma contract manufacturing industry? Development which countries are the hotspots for contract manufacturing? v supply Chain How will consolidation change the dynamics of the industry? v Procurement and what are the key strategies of the leading CMO companies? Purchasing what is the future outlook for the industry? v outsourcing So, why attend this conference? v operations v Contract TOP CMO eveNT IN ASIA Management v Process Development Asia Business Forum’s 2-day Conference is the only CONTRACT MANUFACTURING & v R&D Manufacturing OUTSOURCING FOR PHARMACeUTICAlS CONFeReNCe in Asia you can attend for advanced v Quality Control manufacturing discussions. It offers a unique platform for both client and contractor v Regulatory Affairs to develop new business models for outsourcing and explore on more partnership opportunities. It is a venue to discuss strategies on how to effectively manage costs v Compliance during the economic downturn and discuss win-win solution for the betterment of the pharma industry. legal Advisers, Partners, Solution Providers, vendors THe PReSeNTATIONS The Conference agenda covers a wide range of topics from Pharma’s selection of the right CMo to the contractor’s perspective of improving its capacities. The presentations are also aimed at different levels of the learning curve, so it’s great for beginners to SPONSORSHIP get into the new paradigm of CMo and just as useful for people with experience to ANd exHIbITION learn some new business strategies which they may not have thought of before. OPPORTUNITIeS This high profile event provides your company NeTwORkING OPPORTUNITIeS with the unique opportunity to capture the interest and influence the decisions of a It is a great chance to meet with pharma manufacturing professionals. We have put highly targeted audience. Capitalise on together an impressive line up of top international speakers from USA, CHINA, INdIA, this ideal platform to market your services MAlAySIA and SINGAPORe which you should not miss. and form strategic relationships through networking. Sponsorship and Exhibition options include: wORkSHOP Luncheon Cocktail Reception Piramal, the largest CMo in India, is bringing to the conference its story, best practices, l l l Documentation l Table-Top Display l Promotional Materials effective strategies through a ½-day post-conference workshop. Learn the key to success in outsourcing your manufacture in India. FOR eNqUIRIeS, CAll RejOy PeNACeRRAdA Tel: (65) 6536 8676 MAke CONTRACT MANUFACTURING OUTSOURCING AN INTeGRAl PART OF yOUR bUSINeSS STRATeGy or email: email@example.com Register now and take Advantage of the Super early bird Promotion and save S$400! For enquiries and registration: Call (65) 6536 8676 or (65) 6536 8437 or visit us at www.abf-asia.com REGISTRATION FORM 5 EASY WAYS TO REGISTER ContraCt manufaCturing & Telephone: (65) 6536 8676 or (65) 6536 8437 outSourCing for PharmaCeutiCalS ConferenCe (28-29 OCTOBER 2009) Fax: complete and send this registration form to: & ½-day WorkShoP (30 OCTOBER 2009) Royal Plaza on Scotts Hotel, Singapore (65) 6536 4356 g Yes! Please register the following delegate(s) for this Event Mail: this completed form together with payment to: (Please photocopy for more delegates) Asia Business Forum (Singapore) Pte ltd Please tick (4) your choice session(s) 3 Raffles Place #08-01 Singapore 048617 n 2-Day Conference + ½-Day Workshop [ Oct 28-30, 2009 ] Email: firstname.lastname@example.org n 2-Day Conference only [ Oct 28-29, 2009 ] n ½-Day Workshop [ Oct 30, 2009 ] WEB: http://www.abf-asia.com g I am unable to attend but please put me on your mailing list g I am interested in Sponsorship/Exhibition Opportunities Your investment for attending this Conference is: early Bird Fee Super early Bird Fee Name:(Dr/Mr/Mrs/Ms):____________________________________ Regular Fee (If Payment & registration (If Payment & registration are received by are received by Job Title:_______________________Department:_______________ 28 September 2009) 28 August 2009) Email:___________________________________________________ Conference Only S$2,795 + 7% GST* S$2,595 + 7% GST* S$2,395 + 7% GST* Name:(Dr/Mr/Mrs/Ms):____________________________________ Workshop Only S$ 895 + 7% GST* S$ 895 + 7% GST* S$ 895 + 7% GST* Job Title:_______________________Department:_______________ Conference + Email:___________________________________________________ Workshop S$3,590 + 7% GST* S$3,390 + 7% GST* S$3,190 + 7% GST* Approving Manager:_____________________________________ Note: *GST is only applicable to Delegates from Singapore. The fee includes lunch, refreshments and conference documentation. Job Title:_______________________Department:_______________ Group Discount: Enjoy a group discount of 10% for 3 or more delegates Email:___________________________________________________ registered at the same time from the same organisation and of the same Company:_______________________________________________ billing source. Address:________________________________________________ methodS of Payment ________________________________________________________ g Please cross cheque or bank draft made payable to ASIA Tel:________________________ Fax:_________________________ BUSINeSS FORUM (Singapore) PTe lTD and mail your Booking Contact:_________________________________________ payment together with this registration to 3 Raffles Place, #08-01, Singapore 048617. Enclosed is our cheque/draft for Email:___________________________________________________ S$_________________________________________________ Nature of Business:________________________________________ g Overseas delegates may pay by telegraphic transfer into the Company Web site:________________________________________ account of Asia Business Forum (Singapore) Pte Ltd which is: Account No. 147-070312-001, The Hongkong and ConferenCe Venue and aCCommodation Shanghai Banking Corporation limited, 21 Collyer Quay, information #01-01 HSBC Building, Singapore 049320. Please quote Royal Plaza on Scotts Hotel, Singapore our reference no. 2006S and your Company’s name in your 25 Scotts Road, Singapore 228220 payment instructions. Tel: (65) 6737 7966 Fax: (65) 6737 6646 Website: www.royalplaza.com.sg g Payment by credit card: To make payment by credit card, Attn: Room Reservation Department please call our customer service hotline at (65) 6536 4356 For reservations, please make your bookings directly with the hotel. To enjoy the special room rates, please quote Asia Business Forum’s “CONTRACT MANUFACTURING & OUTSOURCING FOR PHARMACeUTICAlS”. Hotel bills Important Notice: Payments are required with registration and must be received prior are to be settled by delegates directly with the hotel. Hotel reservations and to the Conference to guarantee your place. Walk-in delegates will only be admitted on the travel arrangements are the responsibilities of the registrant. Please note that basis of space availability at the Conference and with immediate full payment. hotel rooms are available on a first-come-first-served basis. inCorreCt mailing information CanCellationS and tranSferS It is possible that you may receive multiple mailings of this event or incorrect If you are unable to attend, a substitute delegate is welcomed at no extra company details on the labels, for which we apologise. If this happens, please let us know so that we can update our database immediately. If you do not wish charge. Please provide the name and the title of the substitute delegate at least to have your name on our mailing list, please let us know and we will remove 2 working days prior to the Conference. A refund less S$300 administration charge will be made for cancellation received in writing on or before 8 October for offiCial uSe 2009. Regrettably, no refund can be made for cancellation received after this date. A complete set of documentation will however be sent to you. FEE RECEIVED ADMISSION FORM SENT 2006S/RP/WT/SDW The organiser reserves the right to make any amendments and/or changes to P CC the programme, venue, speaker replacements and/or topics if warranted by Copyright @ July 2009 circumstances beyond its control.